You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

CVS, Walgreens to administer COVID-19 vaccines at U.S. nursing homes by Jan 25

CVS and Walgreens are currently administering the vaccine in long-term care facilities in 49 states, Washington D.C. and Puerto Rico. Around 35,000 long-term care facilities have partnered with Walgreens, and nearly 8,000 with CVS.

The companies, which run the nation’s largest pharmacy chains but also offer other offsite pharmacy services, have an agreement with the federal government to vaccinate U.S. nursing home residents through a voluntary program.

CVS said most of the residents and staff will be fully vaccinated within three to four weeks of the first visit, depending on the vaccine they receive.

In addition to nursing homes, CVS said it will vaccinate residents and staff at assisted-living facilities, with nearly 31,000 such centers partnering with the company.

####

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Online Event Friday Jan 8 -- Trusting a Covid-19 Vaccine: Who’s Left Unheard?

Center for Strategic and International Studies (CSIS)

Online Event: Trusting a Covid-19 Vaccine: Who’s Left Unheard?

 
Add to Calendar
Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU agency authorizes Moderna's COVID-19 vaccine

AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Warning of Shortages, Researchers Look to Stretch Vaccine Supply

WASHINGTON — Federal officials and drugmakers, faced with a slower-than-expected rollout of the coronavirus vaccine, are racing to find ways to expand the supply, looking at lowering the required dosage and extracting more doses from the supplies they have.

Just weeks into the vaccine program, scientists at the National Institutes of Health and the drugmaker Moderna are analyzing data to see if they can double the supply of the company’s coronavirus vaccine by cutting doses in half. The study, though long planned, is increasingly urgent in the face of looming shortages as the country tries to fight off a surging pandemic.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.854 seconds.